These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 38500373)
1. Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction. Suda M; Paul KH; Tripathi U; Minamino T; Tchkonia T; Kirkland JL Endocr Rev; 2024 Mar; ():. PubMed ID: 38500373 [TBL] [Abstract][Full Text] [Related]
2. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases. Lagoumtzi SM; Chondrogianni N Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756 [TBL] [Abstract][Full Text] [Related]
3. Senolytic drugs: from discovery to translation. Kirkland JL; Tchkonia T J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219 [TBL] [Abstract][Full Text] [Related]
4. National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials. Romashkan S; Chang H; Hadley EC J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1144-1152. PubMed ID: 33528569 [TBL] [Abstract][Full Text] [Related]
5. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies. Khalil R; Diab-Assaf M; Lemaitre JM Cells; 2023 Mar; 12(6):. PubMed ID: 36980256 [TBL] [Abstract][Full Text] [Related]
19. Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases. Kang C Mol Cells; 2019 Dec; 42(12):821-827. PubMed ID: 31838837 [TBL] [Abstract][Full Text] [Related]